On September 9, 2025, the White House and the U.S. Food and Drug Administration (FDA) announced extensive reforms to curb deceptive direct-to-consumer (DTC) pharmaceutical advertising, signaling a dramatic shift toward more aggressive enforcement.[1] Overview On September 9, 2025, the White House directed the Department of Health and Human Services (HHS) and FDA to restore transparency and accountability in prescription drug advertising.[2] In response, FDA sent thousands of letters demanding...
Jonathan Bench
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jonathan
Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack